Researchers developed novel prostaglandin F2alpha receptor antagonists. A specific compound, 5,6-(dibenzyloxy)-1-oxo-2-propyl-2-indanpropionic acid, demonstrated selective PGF2alpha antagonism, indicating its potential for future drug development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: